Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 3rd:
Dropbox, Inc. (DBX): This company that provides a collaboration platform has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.3% over the last 60 days.
Dropbox’s shares gained 14.1% over the last one month against the S&P 500’s decline of 4%. The company possesses a Momentum Score of A.
NanoString Technologies, Inc. (NSTG): This company that provides life science tools for translational research and molecular diagnostic products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.3% over the last 60 days.
NanoString Technologies, Inc. Price and Consensus
NanoString Technologies, Inc. price-consensus-chart | NanoString Technologies, Inc. Quote
NanoString Technologies shares gained 25% over the last one month. The company possesses a Momentum Score of B.
NanoString Technologies, Inc. Price
NanoString Technologies, Inc. price | NanoString Technologies, Inc. Quote
PRA Group, Inc. (PRAA): This financial and business services company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.
PRA Group’s shares gained 7.9% over the last one month. The company possesses a Momentum Score of B.
Cardinal Health (NYSE:CAH), Inc. (CAH): This integrated healthcare services and products company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Cardinal Health, Inc. Price and Consensus
Cardinal Health, Inc. price-consensus-chart | Cardinal Health, Inc. Quote
Cardinal Health’s shares gained 5.4% over the last one month. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
PRA Group, Inc. (PRAA): Free Stock Analysis Report
NanoString Technologies, Inc. (NSTG): Free Stock Analysis Report
Dropbox, Inc. (DBX): Free Stock Analysis Report
Cardinal Health, Inc. (CAH): Free Stock Analysis Report
Original post